Five things you need to know about using CRISPR/Cas9 commercially
By Michael Arciero, vice president of intellectual property and corporate development, ERS Genomics Michael Arciero,…
By Michael Arciero, vice president of intellectual property and corporate development, ERS Genomics Michael Arciero,…
The biotech industry has often been criticized for its lack of gender diversity. While there…
Just a month after the European Patent Office revoked a CRISPR patent from the competitors…
The Broad Institute has been dealt a big blow in its battle for CRISPR/Cas9 intellectual…
Synthetic biology, or synbio for short, is rapidly infiltrating multiple fields. From bioplastics to food…
ERS Genomics has announced that the EPO intends to grant a patent with broad claims…
Evolva is licensing the CRISPR patents of Emmanuelle Charpentier, in a deal with holding company…
Bayer has signed a patent license agreement with ERS Genomics, that controls patents for the…